Literature DB >> 15912050

Clinicopathologic factors associated with false-negative sentinel lymph-node biopsy in breast cancer.

Robert C G Martin1, Anees Chagpar, Charles R Scoggins, Michael J Edwards, Lee Hagendoorn, Arnold J Stromberg, Kelly M McMasters.   

Abstract

SUMMARY BACKGROUND DATA: Previous studies have suggested a variety of factors that may affect the false negative (FN) rate for sentinel lymph node (SLN) biopsy in breast cancer. Because FN results are relatively rare, no prior studies have had sufficient sample size to allow detailed statistical analysis of factors predicting FN results.
METHODS: Patients with clinical stage T1-2, N0 invasive breast cancer were enrolled in a prospective, multicenter study. All patients underwent SLN biopsy, followed by planned completion axillary dissection regardless of the SLN results, to assess the FN rate. SLN biopsy was performed using radioactive colloid injection in combination with isosulfan blue dye in 94% of cases. Dermal, subdermal, peritumoral, or subareolar radioactive colloid injection techniques were used at the discretion of each institution. Univariate and multivariate analyses were performed to identify factors associated with a FN result.
RESULTS: SLNs were identified in 3870 of 4117 patients (94%). There were 1243 true positive, 2521 true negative, and 106 FN results. Age, histologic subtype, the number of non-SLN removed, tumor palpability, type of breast biopsy, and SLN injection technique were not significant factors. On multivariate analysis, tumor size <2.5 cm, upper outer quadrant tumor location, removal of only a single SLN, minimal surgeon experience, presence of a single positive axillary LN, and use of immunohistochemistry (IHC) for SLN analysis were independently associated with an increased risk of FN results.
CONCLUSIONS: Surgeon experience, tumor size and location, and the number of SLN removed are preoperative and intraoperative factors that independently predict the risk of a FN result. In contrast to suggestions from other smaller studies, age does not affect the likelihood of a FN result; a lesser, rather than greater, number of positive axillary nodes was associated with an increased likelihood of a FN result; and IHC analysis of the SLN increases, rather than decreases, the risk of FN results.

Entities:  

Mesh:

Year:  2005        PMID: 15912050      PMCID: PMC1359077          DOI: 10.1097/01.sla.0000165200.32722.02

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  50 in total

1.  Completion axillary lymph node dissection minimizes the likelihood of false negatives for patients with invasive breast carcinoma and cytokeratin positive only sentinel lymph nodes.

Authors:  James W Jakub; Nils M Diaz; Mark D Ebert; Alan Cantor; Douglas S Reintgen; Elisabeth L Dupont; Alan R Shons; Charles E Cox
Journal:  Am J Surg       Date:  2002-10       Impact factor: 2.565

2.  Sentinel node metastasis in patients with breast carcinoma accurately predicts immunohistochemically detectable nonsentinel node metastasis.

Authors:  K U Chu; R R Turner; N M Hansen; M B Brennan; A E Giuliano
Journal:  Ann Surg Oncol       Date:  1999-12       Impact factor: 5.344

3.  Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes.

Authors:  U Veronesi; G Paganelli; V Galimberti; G Viale; S Zurrida; M Bedoni; A Costa; C de Cicco; J G Geraghty; A Luini; V Sacchini; P Veronesi
Journal:  Lancet       Date:  1997-06-28       Impact factor: 79.321

4.  Dermal injection of radioactive colloid is superior to peritumoral injection for breast cancer sentinel lymph node biopsy: results of a multiinstitutional study.

Authors:  K M McMasters; S L Wong; R C Martin; C Chao; T M Tuttle; R D Noyes; D J Carlson; A L Laidley; T Q McGlothin; P B Ley; C M Brown; R L Glaser; R E Pennington; P S Turk; D Simpson; P B Cerrito; M J Edwards
Journal:  Ann Surg       Date:  2001-05       Impact factor: 12.969

5.  Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer.

Authors:  A E Giuliano; P I Haigh; M B Brennan; N M Hansen; M C Kelley; W Ye; E C Glass; R R Turner
Journal:  J Clin Oncol       Date:  2000-07       Impact factor: 44.544

6.  Sentinel lymph node biopsy for breast cancer: a suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used.

Authors:  K M McMasters; T M Tuttle; D J Carlson; C M Brown; R D Noyes; R L Glaser; D J Vennekotter; P S Turk; P S Tate; A Sardi; P B Cerrito; M J Edwards
Journal:  J Clin Oncol       Date:  2000-07       Impact factor: 44.544

Review 7.  College of American Pathologists Conference XXXV: solid tumor prognostic factors-which, how and so what? Summary document and recommendations for implementation. Cancer Committee and Conference Participants.

Authors:  M E Hammond; P L Fitzgibbons; C C Compton; D J Grignon; D L Page; L P Fielding; D Bostwick; T F Pajak
Journal:  Arch Pathol Lab Med       Date:  2000-07       Impact factor: 5.534

8.  Blue dye versus combined blue dye-radioactive tracer technique in detection of sentinel lymph node in breast cancer.

Authors:  Z Radovanovic; A Golubovic; A Plzak; B Stojiljkovic; D Radovanovic
Journal:  Eur J Surg Oncol       Date:  2004-11       Impact factor: 4.424

9.  Accuracy of sentinel lymph node biopsy in patients with large primary breast tumors.

Authors:  I Bedrosian; C Reynolds; R Mick; L S Callans; C S Grant; J H Donohue; D R Farley; R Heller; E Conant; S G Orel; T Lawton; D L Fraker; B J Czerniecki
Journal:  Cancer       Date:  2000-06-01       Impact factor: 6.860

10.  Lymphatic mapping and sentinel node biopsy in the patient with breast cancer.

Authors:  J J Albertini; G H Lyman; C Cox; T Yeatman; L Balducci; N Ku; S Shivers; C Berman; K Wells; D Rapaport; A Shons; J Horton; H Greenberg; S Nicosia; R Clark; A Cantor; D S Reintgen
Journal:  JAMA       Date:  1996-12-11       Impact factor: 56.272

View more
  22 in total

1.  Clinicopathologic factors associated with false-negative sentinel lymph-node biopsy in breast cancer.

Authors:  Hiram S Cody
Journal:  Ann Surg       Date:  2006-08       Impact factor: 12.969

Review 2.  Recent developments in breast-conserving surgery for breast cancer patients.

Authors:  F Fitzal; O Riedl; R Jakesz
Journal:  Langenbecks Arch Surg       Date:  2008-09-10       Impact factor: 3.445

3.  Intraoperative identification of suspicious palpable lymph nodes as an integral part of sentinel node biopsy in patients with breast cancer.

Authors:  Young Jin Choi; Jung Han Kim; Seok Jin Nam; Young Hyeh Ko; Jung-Hyun Yang
Journal:  Surg Today       Date:  2008-04-30       Impact factor: 2.549

4.  Axillary lymph node dissection for sentinel lymph node micrometastases may be safely omitted in early-stage breast cancer patients: long-term outcomes of a prospective study.

Authors:  Igor Langer; Ulrich Guller; Carsten T Viehl; Holger Moch; Edward Wight; Felix Harder; Daniel Oertli; Markus Zuber
Journal:  Indian J Surg Oncol       Date:  2010-08-07

5.  Sentinel Node Biopsy in Special Histologic Types of Invasive Breast Cancer.

Authors:  Montserrat Solà; Mireia Recaj; Eva Castellà; Pere Puig; Josep Maria Gubern; Juan Francisco Julian; Manel Fraile
Journal:  J Breast Health       Date:  2016-04-01

6.  Surgical Management of the Axilla in Breast Cancer Patients with Negative Sentinel Lymph Node: A Method to Reduce False-Negative Rate.

Authors:  Qianqian Yuan; Gaosong Wu; Shu-Yuan Xiao; Yukun He; Kun Wang; Dan Zhang
Journal:  World J Surg       Date:  2019-04       Impact factor: 3.352

7.  Comparison of two models for predicting non-sentinel lymph node metastases in sentinel lymph node-positive breast cancer patients.

Authors:  Giovanni D'Eredita'; Vito Leopoldo Troilo; Fernando Fischetti; Giuseppe Rubini; Tommaso Berardi
Journal:  Updates Surg       Date:  2011-05-31

Review 8.  A comprehensive overview of radioguided surgery using gamma detection probe technology.

Authors:  Stephen P Povoski; Ryan L Neff; Cathy M Mojzisik; David M O'Malley; George H Hinkle; Nathan C Hall; Douglas A Murrey; Michael V Knopp; Edward W Martin
Journal:  World J Surg Oncol       Date:  2009-01-27       Impact factor: 2.754

9.  Suspicious axillary lymph nodes identified on clinical breast MRI in patients newly diagnosed with breast cancer: can quantitative features improve discrimination of malignant from benign?

Authors:  Habib Rahbar; Jane L Conlin; Sana Parsian; Wendy B DeMartini; Sue Peacock; Constance D Lehman; Savannah C Partridge
Journal:  Acad Radiol       Date:  2014-12-06       Impact factor: 3.173

10.  Tumor characteristics influencing non-sentinel lymph node involvement in clinically node negative patients with breast cancer.

Authors:  Gunay Gurleyik; Fugen Aker; Ali Aktekin; Abdullah Saglam
Journal:  J Breast Cancer       Date:  2011-06-18       Impact factor: 3.588

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.